<?xml version="1.0"?> 
<rss version="2.0">

	<channel>
		<title>Precipio, Inc. (PRPO) research, news, and more from GeoInvesting</title>
		<description>The latest research, news, and more from GeoInvesting for Precipio, Inc. (PRPO)</description>
		<link>/companies/prpo_precipio__inc_/overview</link>
		<language>en-us</language>
		<pubDate>Mon, 11 May 2026 14:26:48 GMT</pubDate>
		<lastBuildDate>Mon, 11 May 2026 14:26:48 GMT</lastBuildDate>
        <ttl>120</ttl>
        
        <item><title>Company description</title><guid isPermaLink="false">63658</guid><pubDate>Sat, 14 Feb 2026 13:13:11 GMT</pubDate><description>Precipio is a healthcare biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our products and services deliver higher accuracy, improved laboratory workflow, and ultimately better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in our laboratory where we design, test, validate, and use these products clinically, improving diagnostic outcomes. Precipio then commercializes these technologies as proprietary products that serve the global laboratory community and further scales Precipio&apos;s reach to eradicate misdiagnosis.</description><link>/companies/prpo_precipio__inc_/overview</link></item>
            
	
	</channel>  
	
</rss>
